STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Public ClinicalTrials.gov record NCT00050635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Currently there is an ongoing clinical trial for patients with chemotherapy induced diarrhea. This trial is being conducted to evaluate the efficacy of two dose levels (30 mg and 40 mg) of an investigational drug in reducing the occurrence of severe (Grade 3 or 4) diarrhea during chemotherapy. Eligible patients must either have experienced NCI Common Toxicity Grade 1 - 4 chemotherapy-induced diarrhea during previous chemotherapy treatment or be experiencing Grade 1-4 chemotherapy-induced diarrhea currently. In order to participate in this clinical trial, patients must be male or female 18 years of age or older. Inclusion into this investigational drug trial is based on the protocol entry criteria and a detailed evaluation from a participating trial investigator
Study identification
- NCT ID
- NCT00050635
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 150 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2003 (Type not available)
- Last update posted
- Nov 19, 2009
2002 – 2003
United States locations
- U.S. sites
- 34
- U.S. states
- 17
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kenmar Research Institute | Burbank | California | 91505 | — |
| Bay Area Cancer Research Group | Concord | California | 94520 | — |
| Compassionate Cancer Care medical Group, Inc. | Fountain Valley | California | 92708 | — |
| California Cancer Care, Inc. | Greenbrae | California | 94904-2007 | — |
| Pacific Shores Medical Center | Long Beach | California | 90813 | — |
| Kenmar Research Institute | Los Angeles | California | 90057 | — |
| Oncology Hematology Group of South Florida | Miami | Florida | 33176 | — |
| Pasco Hernando Oncology Associates | New Port Richey | Florida | 34652 | — |
| Mid-Florida Hematology & Oncology Centers, PA | Orange City | Florida | 32763 | — |
| Oncology & Hematology Associates of West Broward | Tamarac | Florida | 33321 | — |
| Creticos Cancer Center | Chicago | Illinois | 60657 | — |
| Decatur Memorial Hospital | Decatur | Illinois | 62526 | — |
| Cancer Care Center | Bloomington | Indiana | 47403 | — |
| Suniti Medical Corporation | Merrillville | Indiana | 46410 | — |
| Genesys Hurley Cancer Institute | Flint | Michigan | 48503 | — |
| Cancer & Hematology Centers of Western Michigan | Grand Rapids | Michigan | 49546 | — |
| Delta Oncology | Greenwood | Mississippi | 38930 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| Heartland Hematology Oncology Associates | Kansas City | Missouri | 64118 | — |
| Arch Medical Services/The Center for Cancer Care and Research | St Louis | Missouri | 63141 | — |
| New Mexico Cancer Care Associates | Santa Fe | New Mexico | 87505 | — |
| North Shore Hematology Oncology | East Setauket | New York | 11733 | — |
| Raleigh Hematology Oncology Associates, Wake Practice | Raleigh | North Carolina | 27609 | — |
| Dakota Clinic/Odyssey Research Services | Fargo | North Dakota | 58103 | — |
| Nashat Y. Gabrail, MD | Canton | Ohio | 44718 | — |
| North Coast Cancer Care, Inc. | Sandusky | Ohio | 44870 | — |
| Lawrence M. Stallings, MD | Wooster | Ohio | 44691 | — |
| Consultants in Medical Oncology-Hematology | Drexel Hill | Pennsylvania | 19026 | — |
| Regional Hematology Oncology Assoc | Langhorne | Pennsylvania | 19047 | — |
| Oncology Services of Aberdeen | Borden | South Dakota | 57401 | — |
| Jones Oncolgy/Hematology Clinic | Germantown | Tennessee | 38138 | — |
| McFaddin Ward Cancer - TOPA | Beaumont | Texas | 77702 | — |
| Scott & White Hospital/CCPC | Waco | Texas | 76702 | — |
| Oncology & Hematology Associates of SW VA | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00050635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2009 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00050635 live on ClinicalTrials.gov.